Dewei Ye
Impact in
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
- Molecular Biology top 5%
- Gut microbiota and health
- Fibroblast Growth Factor Research
- Extracellular vesicles in disease
Papers in
- Epidemiology 19
- Liver Disease Diagnosis and Treatment 15
- Adipokines, Inflammation, and Metabolic Diseases 3
-
- Chronic Kidney Disease and Diabetes 2
- Co-authors
- Aimin Xu (22 shared papers)Yu Wang (7 shared papers)Karen SL Lam (9 shared papers)Ruby L.C. Hoo (7 shared papers)Xiaoyan Hannah Hui (4 shared papers)Tianshi Feng (3 shared papers)Yong Pan (2 shared papers)Jiao Guo (8 shared papers)
- Journals
- Hepatology (3 papers)Research (2 papers)Clinical and Experimental Pharmacology and Physiology (2 papers)Reviews in Endocrine and Metabolic Disorders (2 papers)Nature Communications (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Dewei Ye
49 papers receiving 3.2k citations
Dewei Ye's Hit Papers
Peers
Comparison fields: 5 of 99
- Epidemiology 833
- Molecular Biology 1.1k
- Hepatology 146
- Immunology 302
- Cancer Research 142
Countries citing papers authored by Dewei Ye
This map shows the geographic impact of Dewei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewei Ye more than expected).
Fields of papers citing papers by Dewei Ye
This network shows the impact of papers produced by Dewei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewei Ye. The network helps show where Dewei Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Dewei Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation Hit paper breakdown → | 2019 | 410 |
| 2 | 2019 | 320 | |
| 3 | 2015 | 234 | |
| 4 | 2014 | 176 | |
| 5 | 2012 | 173 | |
| 6 | 2016 | 171 | |
| 7 | 2014 | 164 | |
| 8 | 2016 | 158 | |
| 9 | Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2 Hit paper breakdown → | 2022 | 138 |
| 10 | 2020 | 113 | |
| 11 | 2021 | 89 | |
| 12 | 2020 | 84 | |
| 13 | 2013 | 82 | |
| 14 | 2014 | 70 | |
| 15 | 2022 | 70 | |
| 16 | 2021 | 69 | |
| 17 | 2015 | 67 | |
| 18 | 2020 | 50 | |
| 19 | 2021 | 48 | |
| 20 | 2016 | 47 |
About Dewei Ye
Dewei Ye is a scholar working on Epidemiology, Nephrology, Molecular Biology, Immunology and Hepatology, having authored 52 papers that have together received 3.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (15 papers), Fibroblast Growth Factor Research (5 papers), Gut microbiota and health (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Gestational Diabetes Research and Management (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Epidemiology (833 citations), Molecular Biology (1.1k citations), Hepatology (146 citations), Immunology (302 citations) and Cancer Research (142 citations). Dewei Ye has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Aimin Xu, Yu Wang, Karen SL Lam, Ruby L.C. Hoo, Xiaoyan Hannah Hui, Tianshi Feng, Yong Pan, Jiao Guo, Weiping Jia and Huating Li. Their work appears in journals such as Hepatology, Research, Clinical and Experimental Pharmacology and Physiology, Reviews in Endocrine and Metabolic Disorders and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.